The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Titel:
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Auteur:
Saylor, Philip J. Kozin, Sergey V. Matsui, Aya Goldberg, Saveli I. Aoki, Shuichi Shigeta, Kohei Mamessier, Emilie Smith, Matthew R. Michaelson, M. Dror Lee, Richard J. Duda, Dan G.